1439936-30-7Relevant articles and documents
Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy
Chang, Chia-Chi,Chang, Jia-Ming,Chang, Lien-Hsiang,Chen, Chi-Kuan,Chen, Ching-Hui,Chen, Meng-Hsin,Chern, Ching Yuh,Chuang, Shih-Hsien,Fu, Kuo Chu,Hong, Wan-Hua,Hsueh, Wen-Yun,Huang, Jiann-Jyh,Huang, Kuan Pin,Huang, Lynn Y. L.,Jen, Hsueh-Min,Jian, Pei-Shiou,Lai, Chun-Liang,Lai, Jun-Yu,Lau, Johnson Y. N.,Lee, Yi-Ru,Lee, Ying-Shuan E.,Lin, Her-Sheng,Lin, Yu-Hsiang,Liu, Chia-Wei,Tsai, Pei-Yi,Wang, Yu-Chuan,Wu, Diana ZC.,Wu, Jinn,Yang, Ju-Ying,Yang, Sheng-Chuan,Yu, Kuo-Ming
, (2020/02/29)
Highly expressed in cancer 1 (Hec1) plays an essential role in mitosis and is correlated with cancer formation, progression, and survival. Phosphorylation of Hec1 by Nek2 kinase is essential for its mitotic function, thus any disruption of Hec1/Nek2 prote